These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 24940500)

  • 1. A Phase II Trial of Cetuximab, Gemcitabine, 5-Fluorouracil, and Radiation Therapy in Locally Advanced Nonmetastatic Pancreatic Adenocarcinoma.
    Cetin V; Piperdi B; Bathini V; Walsh WV; Yunus S; Tseng JF; Whalen GF; Wassef WY; Kadish SP; Fitzgerald TJ; Mikule C; Wang Y; Grossman SR
    Gastrointest Cancer Res; 2013 Jul; 6(4 Suppl 1):S2-9. PubMed ID: 24312684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys.
    Guo L; Li Z; Xu B; Yu M; Fu Y; Liu L; Wang J; Luo Y
    Life Sci; 2019 Dec; 238():116967. PubMed ID: 31626794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial.
    Alistar A; Morris BB; Desnoyer R; Klepin HD; Hosseinzadeh K; Clark C; Cameron A; Leyendecker J; D'Agostino R; Topaloglu U; Boteju LW; Boteju AR; Shorr R; Zachar Z; Bingham PM; Ahmed T; Crane S; Shah R; Migliano JJ; Pardee TS; Miller L; Hawkins G; Jin G; Zhang W; Pasche B
    Lancet Oncol; 2017 Jun; 18(6):770-778. PubMed ID: 28495639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Treatment with Endostatin in Combination with Emcitabine, Carboplatin, and Gemcitabine in Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Study.
    Yu X; Zhang L; Chen J
    Open Med (Wars); 2018; 13():142-147. PubMed ID: 29696151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer.
    Han B; Kim BJ; Kim HS; Choi DR; Shim BY; Lee KH; Kim JW; Kim JH; Song H; Kim JH; Park CK; Lee JW; Kim MJ; Zang DY
    J Cancer; 2021; 12(3):912-917. PubMed ID: 33403047
    [No Abstract]   [Full Text] [Related]  

  • 6. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1.
    Guo L; Song N; He T; Qi F; Zheng S; Xu XG; Fu Y; Chen HD; Luo Y
    Mol Carcinog; 2015 Nov; 54(11):1340-53. PubMed ID: 25175281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effect of a novel soluble recombinant human endostatin: administered as a single agent or in combination with chemotherapy agents in mouse tumor models.
    Ren Z; Wang Y; Jiang W; Dai W; Jiang Y
    PLoS One; 2014; 9(9):e107823. PubMed ID: 25229620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells.
    Ricard-Blum S; Vallet SD
    Front Pharmacol; 2016; 7():11. PubMed ID: 26869928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog.
    Wang S; Fu Y; Luo Y
    Chin J Cancer; 2016 Jan; 35():14. PubMed ID: 26792627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of M
    Chen Y; DU Y; Li P; Wu F; Fu Y; Li Z; Luo Y
    Mol Clin Oncol; 2014 Jul; 2(4):586-590. PubMed ID: 24940500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-clinical Efficacy and Safety Pharmacology of PEGylated Recombinant Human Endostatin.
    Guo L; Hua L; Hu B; Wang J
    Curr Mol Med; 2024; 24(3):389-396. PubMed ID: 36999708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pre-clinical safety study of PEGylated recombinant human endostatin (M
    Geng X; Guo L; Liu L; Wang C; Peng Q; Qi W; Sun L; Liu X; Miao Y; Lin Z; Fu Y; Luo Y; Li B
    Regul Toxicol Pharmacol; 2018 Jun; 95():190-197. PubMed ID: 29580973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-clinical toxicokinetics and safety study of M2ES, a PEGylated recombinant human endostatin, in rhesus monkeys.
    Guo L; Geng X; Chen Y; Qi F; Liu L; Miao Y; Lin Z; Yu M; Li Z; Fu Y; Li B; Luo Y
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):512-23. PubMed ID: 24878240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of PEGylated recombinant human endostatin (M2ES) in rats.
    Li ZG; Jia L; Guo LF; Yu M; Sun X; Nie W; Fu Y; Rao CM; Wang JZ; Luo YZ
    Acta Pharmacol Sin; 2015 Jul; 36(7):847-54. PubMed ID: 26027657
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.